As an important regulatory enzyme in cellular glucose metabolism in parasite lifecycles, PYK has become a therapeutic target for infections of parasites including P. falciparum, Trypanosoma, Leishmania, and Babesia microti [65–68]. This evidence concerns the gene PHKA2 and infection.